Benefits of prophylactic emicizumab in enhancing immune tolerance induction in a boy with hemophilia A and very high inhibitor titer

Nongnuch SirachainanAmpaiwan ChuansumritSurapan ParapakpenjunePakawan WongwerawattanakoonSurapong LertthammakiatPraguywan KadegasemWerasak SasanakulFaculty of Medicine Ramathibodi Hospital, Mahidol UniversityMaharaj Nakhon Ratchasima Hospital2022-08-042022-08-042021-09-01Pediatric Blood and Cancer. Vol.68, No.9 (2021)15455017154550092-s2.0-85105949183https://repository.li.mahidol.ac.th/handle/20.500.14594/77926Mahidol UniversityMedicineBenefits of prophylactic emicizumab in enhancing immune tolerance induction in a boy with hemophilia A and very high inhibitor titerLetterSCOPUS10.1002/pbc.29111